Neurokinin receptor antagonists

Expert Opinion on Therapeutic Patents

Volumn 9, Issue 5, 1999, Pages 571-582

  Seward, E M ^a   Swain, C J ^a  

^a NEUROSCIENCE RESEARCH CENTRE   (United Kingdom)

Author keywords

Depression; Emesis; Migraine; Neurokinin; Neurokinin receptor antagonist; Substance P

Indexed keywords

2 BENZHYDRYL 3 (2 METHOXYBENZYLAMINO) 1 AZABICYCLO[2.2.2]OCTANE; 2 BENZYL 1 (3,5 DIMETHYLBENZOYL) 4 (4 QUINOLINYLMETHYLAMINO)PIPERIDINE; 2 [1 [3,5 BIS(TRIFLUOROMETHYL)PHENYL]ETHOXY] 3 (4 FLUOROPHENYL) 4 (3 OXO 1 PHOSPHORYL 1,2,4 TRIAZOL 5 YLMETHYL)MORPHOLINE; 3 (2 METHOXY 5 TRIFLUOROMETHOXYBENZYLAMINO) 2 PHENYLPIPERIDINE; 3 (2 METHOXYBENZYLAMINO) 2 PHENYLPIPERIDINE; 4 (2 METHOXYPHENYL) 2 [2 (2 METHOXYPHENYL)PROPIONYL] 7,7 DIPHENYLPERHYDROISOINDOL 4 OL; APREPITANT; BENZAMIDE DERIVATIVE; DAPITANT; EZLOPITANT; FK 224; LANEPITANT; N BENZYL N2 [4 HYDROXY 1 [(1 METHYL 1H INDOL 3 YL)CARBONYL]PROLYL] N METHYL 3 (2 NAPHTHYL)ALANINAMIDE; NEUROKININ 1 RECEPTOR ANTAGONIST; NEUROKININ 2 RECEPTOR ANTAGONIST; NEUROKININ 3 RECEPTOR ANTAGONIST; ONDANSETRON; QUINUCLIDINE DERIVATIVE; SAREDUTANT; TACHYKININ RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG; [2 METHOXY 5 (1 TETRAZOLYL)BENZYL](2 PHENYL 3 PIPERIDINYL)AMINE;

ASTHMA; CLINICAL TRIAL; DEPRESSION; DRUG STRUCTURE; HUMAN; MIGRAINE; PAIN; PATENT; REVIEW; VOMITING;

EID: 0032937644     PISSN: 13543776     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543776.9.5.571     Document Type: Review

References (30)